{"organizations": [], "uuid": "f54a1289f8fa254373ec8f6e31a214721de7bf62", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180328.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ab-biotics-enters-into-license-agr/brief-ab-biotics-enters-into-license-agreement-with-kaneka-americas-holding-idUSFWN1RA0XE", "country": "US", "domain_rank": 408, "title": "BRIEF-AB-Biotics Enters Into License Agreement With Kaneka Americas Holding", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.307, "site_type": "news", "published": "2018-03-29T00:06:00.000+03:00", "replies_count": 0, "uuid": "f54a1289f8fa254373ec8f6e31a214721de7bf62"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ab-biotics-enters-into-license-agr/brief-ab-biotics-enters-into-license-agreement-with-kaneka-americas-holding-idUSFWN1RA0XE", "ord_in_thread": 0, "title": "BRIEF-AB-Biotics Enters Into License Agreement With Kaneka Americas Holding", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}, {"name": "north america", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "kaneka", "sentiment": "negative"}, {"name": "kaneka americas", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 28 (Reuters) - AB-BIOTICS SA:\n* SAYS ENTERS INTO LICENSE AGREEMENT WITH US COMPANY KANEKA AMERICAS HOLDING\n* SAYS GRANTS EXCLUSIVE RIGHT TO MANUFACTURE AND OFFER CERTAIN AB-BIOTICS PRODUCTS IN JAPAN AND NORTH AMERICA‍​\n* AS PART OF AGREEMENT KANEKA TO BUY 26.86 PERCENT OF AB-BIOTICS SHARE CAPITAL\n* SAYS KANEKA TO BUY 500,000 SHARES THAT COMPANY HAS IN TREASURY STOCK, AT PRICE OF 2.27 EUROS PER SHARE\n* KANEKA COMMITS TO INVEST 490,000 EUROS IN DEVELOPMENT OF COMPANY'S PRODUCTS Source text: bit.ly/2GBuaa1 Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://bit.ly/2GBuaa1", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-29T00:06:00.000+03:00", "crawled": "2018-03-29T15:56:31.065+03:00", "highlightTitle": ""}